Octreotide in bronchobiliary fistula management.
Ong
Michael
M
Moozar
Kouros
K
Cohen
Lawrence B
LB
D000230:Adenocarcinoma / Q000150:complications / Q000556:secondary; D000368:Aged; D001658:Biliary Fistula / Q000188:drug therapy* / Q000601:surgery; D001661:Biliary Tract Neoplasms / Q000150:complications / Q000556:secondary; D001983:Bronchial Fistula / Q000188:drug therapy* / Q000601:surgery; D002760:Cholangiopancreatography, Endoscopic Retrograde; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006323:Heart Arrest / Q000209:etiology; D006801:Humans; D007431:Intraoperative Complications / Q000209:etiology; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy* / Q000601:surgery; D012771:Shock, Hemorrhagic / Q000209:etiology; D015607:Stents; D014682:Vena Cava, Inferior / Q000293:injuries
D015282:Octreotide